Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-08-10

Clinical Trial Update: Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project

View source ↗

Summary

The PET-CT Cetuximab Project trial for metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERBITUX (cetuximab)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Metastatic Colorectal Cancer | Status: TERMINATED